Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jun 4.
Published in final edited form as: Heart Lung. 2013 Mar-Apr;42(2):98–104. doi: 10.1016/j.hrtlng.2013.01.002

Clinical and Socio-demographic Predictors of Postoperative Vital Exhaustion in Patients after Cardiac Surgery

Pamela S Miller a, Lorraine S Evangelista b, Joyce Newman Giger c, Kathleen Dracup d, Lynn V Doering e
PMCID: PMC4455925  NIHMSID: NIHMS435558  PMID: 23453010

Abstract

Background

Vital exhaustion, a psychological state characterized by extreme fatigue, is an independent predictor of future cardiac events. However, the attributes of vital exhaustion following coronary artery bypass (CABG) surgery are poorly understood.

Objective

The study objective was to assess correlates of vital exhaustion following CABG surgery.

Methods

In a descriptive, exploratory study, 42 patients who had CABG surgery were evaluated for exhaustion four to eight weeks post-hospital discharge. Demographic and clinical data were obtained from self-report and medical chart review.

Results

Of the total sample (mean age 67.9±12.5, 90% male, 70% Caucasian, 3.12±1.3 grafts), approximately 41% reported exhaustion. When compared to their exhausted post-CABG counterpart, non-exhausted post-CABG patients had a significantly higher frequency of preoperative insulin use. Exhausted patients were significantly more likely to have higher left ventricular ejection fraction ([LVEF], OR 1.07, p=0.04), and elevated hemoglobin (OR 2.98, p=0.03) and eosinophils (OR 1.02, p=0.02) than those who were not exhausted.

Conclusion

Clinicians should evaluate all patients for exhaustion post-CABG surgery; patients with elevated LVEF, hemoglobin, and eosinophil levels warrant increased scrutiny.

Keywords: Cardiac surgery, Coronary artery bypass graft, Predictors, Risk factors, Vital exhaustion

INTRODUCTION

Approximately 16.3 million Americans have coronary heart disease (CHD),1 one of the leading causes of death and disability burden worldwide.2 Fatigue is among the most common prodromal symptom in acute myocardial infarction.35 The experience of fatigue has been documented weeks after coronary artery bypass graft (CABG) surgery, and associated with impaired psychosocial and physical functioning and decreased quality of life.6 Vital exhaustion (hereafter referred to as exhaustion) is a psychological state characterized by extreme fatigue, lack of energy, general malaise, irritability, and demoralization, and is possibly related to numerous physiological variables.7 Prevalence of exhaustion among those with CHD reportedly ranges from 35% – 75%.8, 9 Exhaustion has been identified as an independent prognostic indicator of coronary artery disease morbidity and mortality with a two- to three-fold increase in future cardiac events (e.g. myocardial infarction, repeat revascularization, recurrent angina, and re-hospitalization).10, 11

Previous investigators have reported a variety of socio-demographic and clinical characteristics such as age, gender, race/ethnicity, socioeconomic status, education, body mass index, weight gain, smoking, diabetes, hypertension, and New York Heart Association classification as associated with exhaustion.1215 Individuals with higher exhaustion scores were more likely to be female11, 12 and African American.16 Surrogates of socioeconomic status (e.g. income, education) were significantly associated with exhaustion in patients with a history of CHD; individuals with low and middle income levels and elementary or high school education have a higher probability of becoming exhausted compared to those with high income or educational attainment beyond high school.17 Several investigators also identified physiologic correlates of exhaustion including elevated inflammatory markers (e.g. interleukin-6, tumor necrosis factor-alpha, C-reactive protein);1821 suppression of cortisol;22 abnormal lipid metabolism (e.g. elevated triglycerides and low levels of high-density lipoprotein);23, 24 and impaired fibrinolytic activity (e.g. elevated fibrinogen and plasminogen activator inhibitor-1).25, 26

To our knowledge, only two studies by Boudrez and colleagues27, 28 involved CABG patients, a population generally characterized by advanced age and high-grade, multivessel disease. In these two studies, the investigators examined the temporal change in exhaustion scores pre- and post-operatively. Boudrez et al.27 observed significant gender differences, with women reporting higher pre-CABG exhaustion levels compared to men; these pre-CABG gender differences had disappeared by 4-months post-CABG. Findings from the study by Boudrez and De Backer28 revealed significant overall improvement in exhaustion scores between pre-CABG and six-months post-CABG. While these two studies constitute an important contribution to the literature on exhaustion, clinical and socio-demographic predictors of exhaustion in the CABG population have yet to be identified.

The aim of this descriptive, exploratory study was to determine whether preoperative socio-demographic and clinical variables were predictive of postoperative exhaustion in patients after CABG surgery. Discriminating between patients with exhaustion and non-exhaustion on the basis of clinical and socio-demographic factors may provide clinicians with insight for early assessment and secondary prevention strategies in order to attenuate disease progression and minimize future cardiac events. More importantly, findings may broaden our understanding of potential mechanisms by which exhaustion influences CHD and its adverse sequelae in the post-CABG population.

METHODS

Study Design and Sample

A descriptive, exploratory study design was conducted at two cardiac centers at a university-affiliated public healthcare institution and federal tertiary care facility. Subjects were a convenience sample of 42 patients (mean age 67.9±12.54, 90% male, 70% Caucasian) who underwent CABG. Medical records were reviewed for eligibility criteria. Patients were included in the study if they were 45 years of age or older and underwent CABG surgery within the past four to eight weeks. Patients were excluded if they were clinically depressed; diagnosed with malignancy, autoimmune disorder, or active infection; a current smoker; were actively being treated for mood or affective disorders; or had postoperative complications (e.g. stroke, reoperation, sternal wound infections, pneumonia, readmission, and myocardial infarction) that would have influenced exhaustion within eight weeks of hospital discharge for CABG surgery.

Procedures

The Institutional Review Board of the participating sites approved the study protocol, and all participants provided written informed consent. Data were collected by medical record review, patient interview, and written questionnaires. Participants underwent one study visit during morning hours in a location convenient for the patient (e.g. patient’s home or outpatient clinic) for data collection between four to eight weeks post-hospital discharge. This time point was used to minimize the influence of wound healing as patients were more likely to have inflammatory profiles similar to their preoperative baseline levels.29

Variables and Measures

Depression Screening

Patients were initially screened for the presence of depression disorder because of its potential overlap with exhaustion using the Patient Health Questionnaire-2. 30 Participants selected from among four responses for each item (not at all, several days, more than half the days, and nearly every day), and each response was scored as 0, 1, 2, and 3, respectively.30 The Patient Health Questionnaire-2 scores can range from 0 to 6. The standard cut point of ≥ 3 to identify depression was utilized.30 Sensitivity and specificity for the Patient Health Questionnaire-2 is reportedly 83% and 90%, respectively, with a positive likelihood ratio of 2.9.30 The questionnaire has been recommended for depression screening in the cardiovascular population by the interdisciplinary expert consensus of the National Heart, Lung, and Blood Working Group.31

Exhaustion

Participants were asked to complete the Maastricht Interview for Vital Exhaustion (MIVE), a 23-item standardized interview that measures the presence of exhaustion and includes questions regarding unusual fatigue, loss of energy, increased irritability, and feelings of demoralization.32 Scores range from a minimum of 0 to a maximum of 23. In the current study, Cronbach’s alpha for the MIVE was 0.85, indicating good reliability. Participants were designated as exhausted if they endorsed ≥ 7 out of 23 MIVE items.33

Medical Record Review and Patient Interview

A diverse group of socio-demographic and clinical variables were selected for study based on their theoretical relevance to the phenomenon of exhaustion (e.g.7, 17, 23, 34). Socio-demographic data, medical history, cardiovascular risk factors, and current medication regimen were collected by patient interview and verified by medical record review. The preoperative complete blood count was obtained by medical record review. Two trained researchers with experience in data abstraction and no prior knowledge of patients’ exhaustion status independently reviewed patient medical records. Interrater reliability (κ) was 0.95.

For socio-demographics, data were categorized as follows: gender (male vs. female); race/ethnicity (Caucasian vs. non-Caucasian); education (more than high school vs. high school or less); annual income (> $40,000 vs. ≤ $40,000); marital status (married or cohabitating vs. single, divorced, and widowed); and employment status (employed vs. retired and unemployed). For clinical characteristics, variables were defined as follows: cardiopulmonary bypass (off-pump vs. on-pump vs. combination) and procedural status (elective vs. emergent). Medical history, cardiovascular risk factors, coronary vessel involvement, and postoperative medications were dichotomized into no/yes categories. All other variables were reported as continuous data.

Data Analysis

Descriptive statistics were used to summarize the sample data. T-test, chi-square or Fisher’s Exact were used for between-group comparisons (exhausted vs. non-exhausted) of all socio-demographic and clinical predictor variables. Effect sizes were calculated using d and h estimates for respective mean and proportional group differences as established by Cohen:35 0.20 – 0.50 small, 0.50 – 0.80 moderate, and ≥ 0.80 large effect size. Multiple stepwise logistic regression was conducted to identify preoperative socio-demographic and clinical predictors with postoperative exhaustion status using entry criteria at 0.05 and elimination criteria at 0.10. Variables with a bivariate significance of p ≤ 0.10 were entered into the regression analyses to determine the best model of predictors for exhaustion. Variables included: age, gender, marital status, left ventricular ejection fraction (LVEF), body mass index, preoperative hemoglobin, hematocrit and eosinophils, diuretic use, insulin use, older than 65 years of age, RCA disease, posterior lateral disease, previous angina, and valvular disease. Significance level was set at α ≤ 0.05. Log transformations were used to approximate normal distributions of hematologic data. All statistical analyses were performed using SPSS version 17 (SPSS, Inc., Chicago, Illinois).

RESULTS

Sample Socio-demographics and Clinical Characteristics

Socio-demographic and clinical characteristics of post-CABG patients with and without exhaustion are presented in Table 1 and Table 2. In the sample of 42 post-CABG patients with a mean age of 67.5 years, substantially more males and Caucasians were enrolled in the study than females and racial/ethnic minorities. On average, post-CABG patients underwent three bypass grafts. High-grade culprit atherosclerotic lesions in the left anterior descending artery as documented by prior cardiac angiography were most common followed by left main, left circumflex, and right coronary artery (RCA). Over half of the total sample had 3-vessel disease. The most frequent preoperative medical history included previous angina, valvular disease, myocardial infarction, and heart failure.

Table 1.

Socio-demographic characteristics according to exhaustion status

Variable Total Sample (n = 42)
Mean ± SD
Exhaustion (n = 17)
Mean ± SD
No Exhaustion (n = 25)
Mean ± SD
P ES (d)
Age 67.5±12.6 63.4 ± 9.5 70.1 ± 13.7 0.07 −0.54
N (%) N (%) P ES (h)

Gender 0.08
Male 38 (90) 17 (100) 21 (84) 0.82
Female 4 (10) 0 4 (16) −0.82
Race/Ethnicity 0.37
Caucasian 28 (67) 10 (59) 18 (72) −0.27
Black 3 (7) 1 (6) 2 (8) −0.08
Hispanic 2 (5) 2 (12) 0 0.71
Asian/Pacific Islander 9 (21) 4 (23) 5 (20) 0.07
Education 1.00
More than High school 34 (83) 13 (81) 21 (84) −0.08
High school or less 7 (17) 3 (19) 4 (16) 0.08
Annual Income 0.57
≤ $20,000 8 (19) 3 (18) 5 (20) −0.05
> $20,000 – $40,000 12 (29) 6 (35) 6 (24) 0.24
> $40,000 – $60,000 8 (19) 2 (12) 6 (24) −0.32
> $60,000 14 (33) 6 (35) 8 (32) 0.06
Marital Status 0.09
Married or cohabitating 27 (64) 15 (88) 12 (48) 0.90
Divorced 1 (3) 0 1 (4) −0.40
Widowed 8 (19) 1 (6) 7 (28) −0.62
Single 6 (14) 1 (6) 5 (20) −0.43
Employment Status 0.28
Retired/Unemployed 24 (57) 8 (47) 16 (64) −0.34
Employed 14 (33) 6 (35) 8 (32) 0.06
Self-employed 4 (10) 3 (18) 1 (4) 0.47

d, Cohen’s d; ES, effect size; h, Cohen’s h; SD, standard deviation.

*

p < 0.05

Table 2.

Clinical characteristics by exhaustion status

Variable Total Sample (n = 42)
Mean ± SD
Exhaustion (n = 17)
Mean ± SD
No Exhaustion (n = 25)
Mean ± SD
P ES (d)
LV Ejection Fraction (%) 52.61±12.5 57.9 ± 10.9 49.2 ± 12.5 0.03* 0.72
Body Mass Index 27.66±4.2 28.9 ± 4.3 26.8 ± 3.0 0.08 0.58
Highest Degree of Stenosis (%) 89.60±12.6 89.7 ± 12.4 89.5 ± 13.0 0.96 0.02
Total # of Bypass Grafts 3.12±1.3 3.5 ± 1.2 2.9 ± 1.3 0.15 0.47

Preoperative Hematology
WBC (×1000/uL) 6.6±1.9 7.0 ± 2.1 6.3 ± 1.7 0.27 0.37
Lymphocytes (/uL) 1612.0±515.9 1672.7 ± 645.1 1564.3 ± 406.9 0.61 0.21
Neutrophils (/uL) 4051.72±1515.1 4316.7 ± 1428.2 3864.7 ± 1589 0.44 0.29
Monocytes (/uL) 531.03±167.1 516.7 ± 169.7 541.2 ± 169.8 0.71 −0.14
Eosinophils (/uL) 167.86±98.3 208.3 ± 99.6 137.5 ± 88.5 0.06 0.75
RBC (M/uL) 4.42±0.5 4.5 ± 0.5 4.3 ± 0.5 0.34 0.39
Hemoglobin (g/dL) 13.47±1.5 14.0 ± 1.6 13.1 ± 1.4 0.08 0.56
Hematocrit (%) 39.85±4.1 41.1 ± 4.3 39.0 ± 3.8 0.11 0.51
Platelets (k/uL) 232.48±50.7 231.6 ± 49.7 233.2 ± 53.0 0.93 −0.03

N (%) N (%) P ES (h)

Procedural Status 0.67
Elective CABG 36 (86) 14 (82.4) 22 (88) −0.17
Emergent CABG 6 (14) 3 (17.6) 3 (12) 0.17

Cardiopulmonary Bypass 0.68
On-pump 39 (93) 16 (94.1) 23 (92) 0.08
Off-pump 2 (5) 1 (5.9) 1 (4) 0.09
Combination On-pump/Off-pump 1 (2) 0 1 (4) −0.40

Cardiovascular Risk Factors
Family History of CAD 10 (24) 6 (35) 4 (16) 0.15 0.44
Hypertension 36 (86) 15 (88) 21 (84) 0.70 0.12
Hyperlipidemia 34 (81) 15 (88) 19 (76) 0.32 0.32
Diabetes Mellitus 23 (55) 10 (59) 13 (52) 0.66 0.14
History of Tobacco Use 29 (69) 14 (82) 15 (60) 0.12 0.49
Age > 65 years 20 (48) 5 (29) 15 (60) 0.05 −0.64
Physical Inactivity 31 (74) 13 (77) 18 (72) 0.39 0.12

Medications
Aspirin 38 (91) 16 (94) 22 (88) 0.51 0.21
Clopidigrel 19 (45) 9 (53) 10 (40) 0.41 0.26
ACE Inhibitors 17 (41) 8 (47) 9 (36) 0.47 0.22
Beta Blockers 40 (95) 17 (100) 23 (92) 0.23 0.57
Statins 38 (91) 15 (88) 23 (92) 0.68 −0.13
Diuretics 33 (79) 11 (65) 22 (88) 0.07 −0.56
Nitrates 6 (14) 3 (18) 3 (12) 0.61 0.17
Insulin 8 (19) 0 8 (32) 0.01* −0.90
Oral Hypoglycemic Agents 14 (33) 6 (35) 8 (32) 0.82 0.06

CAD Vessel Involvement
Left Main 13 (31) 5 (29) 8 (32) 0.86 −0.07
Left Anterior Descending 39 (93) 17 (100) 22 (88) 0.14 0.71
Circumflex 29 (69) 13 (77) 16 (64) 0.39 0.29
Right Coronary Artery 28 (67) 14 (82) 14 (56) 0.08 0.57
Posterior Lateral 3 (7) 3 (18) 0 0.03* 0.88

Preoperative Medical Hx
Myocardial Infarction 14 (33) 6 (35) 8 (32) 0.82 0.06
Angina 25 (60) 13 (77) 12 (48) 0.07 0.61
Heart Failure 7 (17) 2 (12) 5 (20) 0.32 −0.22
Valvular Disease 17 (41) 4 (24) 13 (52) 0.06 0.59

ACE, angiotensin-converting enzyme; CABG, coronary artery bypass graft; CAD, coronary artery disease; d, Cohen’s d; ES, effect size; h, Cohen’s h; Hx, history; LV, left ventricular; RBC, red blood count; SD, standard deviation; WBC, white blood count.

*

p < 0.05

Seventeen patients (40.5%) were exhausted versus 25 (59.5%) who were not exhausted. Bivariate analyses revealed that both groups were comparable in terms of age, gender, race/ethnicity, marital status, and educational level. Exhausted subjects had higher LVEF and a non-significant trend toward higher body mass index. Interestingly, the presence of stenotic lesions in the posterior lateral artery was found to be significantly higher in the exhausted group compared to the non-exhausted group. There were no significant differences in the mean number of bypass grafts or diseased vessels, procedural status (elective vs. emergent) or cardiopulmonary bypass status (on-pump vs. off-pump vs. combination) as surrogates for surgical approach, and history of angina and valvular disease. Likewise, the prevalence of cardiovascular risk factors (premature family history of CHD, male gender, hypertension, hyperlipidemia, diabetes, smoking, alcohol use, and physical inactivity) was not significantly different among exhausted and non-exhausted subjects. There was a non-significant trend towards a higher frequency of patients older than 65 years in the non-exhausted group compared to the exhausted group. A significantly higher frequency of preoperative insulin users occurred in the non-exhausted group compared to the exhausted group; all other treatment regimens were similar in the two groups. Preoperative hemoglobin levels and eosinophil counts were higher in exhausted patients than non-exhausted patients, but the differences were not significant.

Predictors of Exhaustion

Table 3 provides unadjusted univariate and multiple logistic regression analyses for predictors in the final model. In the univariate model, higher LVEF was significantly predictive of exhaustion compared to non-exhaustion. There was a non-significant trend towards higher eosinophil count and hemoglobin levels as increasing the odds of exhaustion as opposed to non-exhaustion. In the full model, both higher eosinophil concentration and hemoglobin were significant independent predictors of exhaustion, independent of LVEF. For every 1-unit increase in hemoglobin levels, the odds of being exhausted versus non-exhausted were increased by a factor of 2.98. Additionally, the odds of post-CABG exhaustion were 2.1% greater with every 1-unit increase in preoperative eosinophil concentration than for those without exhaustion. There was negligible confounding in the effect of LVEF, hemoglobin, and eosinophils on exhaustion when adjusting for socio-demographic factors (age, gender, and marital status). Taken together, LVEF, hemoglobin level, and eosinophil count accounted for 59% of the variance in exhaustion.

Table 3.

Logistic regression analyses to identify predictors of exhaustion risk (n=41)

Univariate Logistic Regression Model Multiple Logistic Regression Modela

OR 95% CI P OR 95% CI P

LVEF (%) 1.067 1.067 – 1.136 0.039 1.118 0.990 – 1.263 0.070
Eosinophil Count (/uL) 1.008 0.999 – 1.018 0.070 1.021 1.004 – 1.038 0.015
Hemoglobin (g/dL) 1.488 0.945 – 2.343 0.086 2.978 1.097 – 8.085 0.032
a

Multiple Logistic Regression Model (unadjusted): Model χ2 = 15.54, df 3, P = 0.001; Hosmer–Lemeshow statistic: χ2 = 3.33, df 7, P = 0.85, Nagelkerke R 2 = 0.59

Independent variables were continuous.

CI, confidence interval; df, degrees of freedom; OR, odds ratio; SE, standard error; LVEF, left ventricular ejection fraction.

DISCUSSION

Our findings showed that 40.5% of the participants in our study were exhausted four to eight weeks after their CABG surgery. These findings are comparable to earlier studies that confirmed a moderately high level of exhaustion in both the pre- and post-operative CABG population.27, 28 However, less is known about correlates of exhaustion in the CABG population. To our knowledge, this is the first study to identify clinical factors as independent predictors of postoperative CABG exhaustion. Patients with increases in LVEF, hemoglobin, and eosinophil count were more likely to be exhausted than were those without exhaustion. Notably, LVEF was found to be a significant predictor in the univariate but not multivariable analyses. Clinical factors were more robust predictors of exhaustion when compared to socio-demographic factors, which may be ascribed to the underlying pathophysiological mechanisms that mediate exhaustion with CHD and suggestive of the association between somatic symptoms and exhaustion as recently reported by Vroege, Zuldersma, and de Jonge.36 In this sample of post-CABG patients, socio-demographic variables accounted for less than 3% of the variance when included in the final model, thereby providing a relatively small contribution in explaining exhaustion.

A counterintuitive finding in our study was that a significantly higher mean LVEF preoperatively was associated with exhaustion post-CABG. There was a 7% increase in the odds of post-CABG exhaustion versus non-exhaustion with increases in preoperative LVEF. In prior studies, the relationship between exhaustion and LVEF has been mixed with negative37, 38,39 and positive40 results among individuals with CHD and heart failure. Our counterintuitive results might be best elucidated by two plausible explanations. First, our finding suggests that poor cardiac function in the preoperative period was not a predictor of exhaustion among individuals after CABG; in other words, post-CABG exhaustion may not be a consequence of dysfunctional cardiac pathology. This new finding of higher preserved left ventricular function among exhausted subjects may be the result of ischemic but viable myocardium and/or preoperative medication management (e.g. beta blockers).41 The complexity of the relationship between increasing LVEF and exhaustion may involve various physiologic mechanisms not examined in this study. Secondly, the comorbidity of psychosocial factors such as lack of social support and hostility were unmeasured in this study, but may trigger mental stress. Mental stress has been shown to induce myocardial ischemia and is associated with decreased LVEF, and subsequent adverse clinical outcomes (e.g. mortality, myocardial infarction) in patients with CHD.42 Although this relationship is unexpected, a paradoxical relationship has been previously described which supports further exploration of the relationship between LV function and exhaustion in a larger sample.

Normal but increasing levels of preoperative hemoglobin predicted exhaustion among post-CABG patients. We have no clear explanation for the association between hemoglobin and exhaustion; this finding will warrant further investigation. We were unable to ascertain whether higher hemoglobin levels were a consequence of increased red blood cell production. Elevated hemoglobin levels may be caused by conditions such as pulmonary disease, heart failure, polycythemia vera, and smoking. Both hemoglobin concentration and exhaustion were positively correlated with hematocrit levels in this study, and hemoglobin and hematocrit are among several factors that may influence blood viscosity.43 Higher blood viscosity may compromise the blood’s oxygen delivery by promoting red blood cell aggregation, reducing coronary blood flow, augmenting platelet and leukocyte adhesion to the endothelium, and increasing risk of thrombosis.44 It remains to be determined whether our finding reveals an inflammatory-thrombotic pathway linking exhaustion to adverse cardiac outcomes.

We observed a novel association between preoperative absolute eosinophil count and postoperative exhaustion. Eosinophils account for approximately 1–4% of peripheral leukocytes, and are implicated in the immune response against parasitic infections, allergic disorders, tumors, and gastrointestinal disorders.45 When activated, these granulated immune cells modulate innate and adaptive immunity through various mechanisms, which include the release of preformed biochemically active protein mediators and cytokines, antigen presentation, and phagocytosis. Although speculative, the link between exhaustion and eosinophils may be rooted in the recruitment of eosinophils by immunomodulators such as cytokines (e.g. IL-8).

Elevated eosinophils may reflect the pathological burden of atherosclerotic disease.46, 47,48 Recent evidence suggests that eosinophils play an important role in thrombus formation and coronary occlusion via coagulation and platelet activation pathways in acute coronary syndromes.49, 50 Relationships between fatigue, depression and elevated eosinophil percentages have been reported in cancer research.51 Interestingly, increased concentrations of eosinophil-selective chemokine, eotaxin, and eosinophil activation marker, eosinophil cationic protein, were observed in chronic fatigue syndrome and coronary atherosclerosis.52, 53 This finding highlights a plausible immune-mediated inflammatory mechanism by which exhaustion may promote cardiovascular morbidity and mortality after cardiac surgery. Post hoc analyses did not reveal any correlation between eosinophils and cardiovascular risk factors or other comorbid diseases in the present study.

Another interesting finding was the statistically significant difference among exhausted and non-exhausted groups for preoperative insulin use. All eight subjects on insulin for diabetes were in the non-exhausted group. Hyperglycemia potentiates atherosclerosis progression through several mechanisms which includes indirectly activating NF-κB transcription of pro-inflammatory cytokine genes.54 Exhaustion has been shown to be positively associated with glucose and insulin/glucose ratio.55 Our finding is consistent with previous work demonstrating that insulin has significant anti-inflammatory effects. Insulin exerts its anti-atherogenic effects on the vessel wall by inducing endothelial nitric oxide synthase, which stimulates nitric oxide production, increases vascular blood flow, and attenuates pro-atherogenic intercellular adhesion molecule-1 upregulation, monocyte chemoattractant protein-1 expression, and NF-κB signaling.56 The anti-atherogenic effects of insulin may interfere with the pro-inflammatory and pro-atherogenic association that characterizes exhaustion. Hence, in the current study, non-exhausted status may be attributed to, in part, the anti-inflammatory effects of insulin.

Limitations

Several limitations to our results should be acknowledged. The study sample was small; therefore, it is possible that a lack of statistical power undermined the ability to reveal significant differences and associations. In spite of a small sample size, effect sizes were large enough to detect reported differences and associations. Given the exploratory nature of this study, no corrections were applied to the alpha for multiple comparisons, which preserved power. Exact p values have been made available in order to draw inferences, which may include informal adjustments for multiple testing. Generalizability of the findings is limited; this study was conducted with a population of post-CABG patients that were highly educated and predominantly white with high household income levels. To determine whether the conclusion of this study is applicable and useful to more diverse CABG patients, further study in larger heterogeneous samples is warranted. There were no objective measures of functional status or New York Heart Association classification to correlate with exhaustion. Personality traits may influence exhaustion and warrant consideration in future analyses in addition to behavioral and psychosocial factors such as stress, anxiety, sleep, and physical activity. The results of the present study would benefit from confirmation in a larger sample, which would provide greater predictive power of the identified factors.

A couple of points are noteworthy. First, the timing of the assessment of exhaustion may be influenced by the presence of somatic symptoms following cardiac surgery. Previous investigators observed no significant difference in exhaustion levels before CABG or three to four weeks after CABG surgery;28 however, such differences were observed at four months postoperatively.27 We found no association between time since surgery and exhaustion. Second, although a proportionally shared variance has been reported between exhaustion and depression,57 there are distinct conceptual differences. At the time of this study, evidence suggested that ‘depressed mood,’ and loss of self-esteem were virtually absent in exhausted patients.39 Therefore, criteria to exclude depressed patients was used to remove the confounding influence of depression and increase the construct validity of the study; there were no exclusions by this process. Further study is required to tease out the relationship between depression and exhaustion.

Conclusions

In summary, the association of exhaustion following CABG with higher preoperative LVEF, hemoglobin, and eosinophil concentrations is novel. While the findings do not establish causal associations, they may suggest complex physiologic pathways by which exhaustion exerts its influence in post-CABG patients. Clinicians should evaluate all patients for exhaustion post-CABG surgery; patients with elevated LVEF, hemoglobin, and eosinophil levels warrant increased scrutiny. Identifying preoperative risk factors for exhaustion may increase our ability to target patients in whom exhaustion may hamper surgical recovery.

Acknowledgments

The authors wish to thank Dr. Otoniel Martinez-Maza for his careful review of this paper.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Contributor Information

Pamela S. Miller, Email: pamela.miller@ucsf.edu.

Lorraine S. Evangelista, Email: l.evangelista@uci.edu.

Joyce Newman Giger, Email: jgiger@sonnet.ucla.edu.

Kathleen Dracup, Email: kathy.dracup@nursing.ucsf.edu.

Lynn V. Doering, Email: ldoering@sonnet.ucla.edu.

References

  • 1.Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012;125:e12–e230. doi: 10.1161/CIR.0b013e31823ac046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–57. doi: 10.1016/S0140-6736(06)68770-9. [DOI] [PubMed] [Google Scholar]
  • 3.Kuller L. Prodromata of sudden death and myocardial infarction. Adv Cardiol. 1978;25:61–72. doi: 10.1159/000402006. [DOI] [PubMed] [Google Scholar]
  • 4.Lovlien M, Johansson I, Hole T, Schel B. Early warning signs of an acute myocardial infarction and their influence on symptoms during the acute phase, with comparisons by gender. Gender Medicine. 2009;6:444–53. doi: 10.1016/j.genm.2009.09.009. [DOI] [PubMed] [Google Scholar]
  • 5.McSweeney JC, O’Sullivan P, Cleves MA, Lefler LL, Cody M, Moser DK, et al. Racial differences in women’s prodromal and acute symptoms of myocardial infarction. Am J Crit Care. 2010;19:63–73. doi: 10.4037/ajcc2010372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Barnason S, Zimmerman L, Nieveen J, Schulz P, Miller C, Hertzog M, et al. Relationships between fatigue and early postoperative recovery outcomes over time in elderly patients undergoing coronary artery bypass graft surgery. Heart Lung. 2008;37:245–56. doi: 10.1016/j.hrtlng.2007.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Appels A. Exhaustion and coronary heart disease: the history of a scientific quest. Patient Educ Couns. 2004;55:223–9. doi: 10.1016/j.pec.2003.09.008. [DOI] [PubMed] [Google Scholar]
  • 8.Pedersen SS, Middel B. Increased vital exhaustion among type-D patients with ischemic heart disease. J Psychosom Res. 2001;51:443–9. doi: 10.1016/s0022-3999(01)00203-3. [DOI] [PubMed] [Google Scholar]
  • 9.Kop W. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med. 1999;61:476–87. doi: 10.1097/00006842-199907000-00012. [DOI] [PubMed] [Google Scholar]
  • 10.Kop W, Appels AP, Mendes de Leon CF, de Swart HB, Bar FW. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med. 1994;56:281–7. doi: 10.1097/00006842-199407000-00001. [DOI] [PubMed] [Google Scholar]
  • 11.Smith ORF, Kupper N, Denollet J, de Jonge P. Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failure: predictive power of different trajectories. Psychol Med. 2011;41:731–8. doi: 10.1017/S0033291710001133. [DOI] [PubMed] [Google Scholar]
  • 12.Williams JE, Mosley TH, Jr, Kop WJ, Couper DJ, Welch VL, Rosamond WD. Vital exhaustion as a risk factor for adverse cardiac events (from the Atherosclerosis Risk In Communities [ARIC] Study) Am J Cardiol. 2010;105:1661–5. doi: 10.1016/j.amjcard.2010.01.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Schuitemaker GE, Dinant GJ, van der Pol GA, Appels A. Assessment of vital exhaustion and identification of subjects at increased risk of myocardial infarction in general practice. Psychosomatics. 2004;45:414–8. doi: 10.1176/appi.psy.45.5.414. [DOI] [PubMed] [Google Scholar]
  • 14.Skodova Z, van Dijk J, Nagyova I, Rosenberger J, Ondusova D, Studencan M, et al. Psychosocial factors of coronary heart disease and quality of life among Roma coronary patients: a study matched by socioeconomic position. Int J Public Health. 2010;55:373–80. doi: 10.1007/s00038-010-0153-4. [DOI] [PubMed] [Google Scholar]
  • 15.Bryant MJ, Stevens J, Truesdale KP, Mosley T, Chambless L. Obesity and vital exhaustion: Analysis of the Atherosclerosis Risk in the Communities study. Obesity. 2008;16:1545–51. doi: 10.1038/oby.2008.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cheung N, Rogers S, Mosley TH, Klein R, Couper D, Wong TY. Vital exhaustion and retinal microvascular changes in cardiovascular disease: Atherosclerosis Risk in Communities study. Psychosom Med. 2009;71:308–12. doi: 10.1097/PSY.0b013e318190f009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Skodova Z, Nagyova I, Rosenberger J, van Dijk JP, Middel B, Vargova H, et al. Vital exhaustion in coronary heart disease: the impact of socioeconomic status. Eur J Cardiovasc Prev Rehabil. 2008;15:572–6. doi: 10.1097/HJR.0b013e3283078efb. [DOI] [PubMed] [Google Scholar]
  • 18.Sjorgren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relation to psychosocial factors: Studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain Behav Immun. 2006;20:270–8. doi: 10.1016/j.bbi.2005.08.001. [DOI] [PubMed] [Google Scholar]
  • 19.Wirtz PH, von Kanel R, Schnorpfeil P, Ehlert U, Frey K, Fischer JE. Reduced glucocorticoid sensitivity of monocyte interleukin-6 production in male industrial employees who are vitally exhausted. Psychosom Med. 2003;65:672–8. doi: 10.1097/01.psy.0000062529.39901.c7. [DOI] [PubMed] [Google Scholar]
  • 20.Appels A, Bar FW, Bar J, Bruggeman C, de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med. 2000;62:601–5. doi: 10.1097/00006842-200009000-00001. [DOI] [PubMed] [Google Scholar]
  • 21.Meyer T, Stanske B, Kochen MM, Cordes A, Yuksel I, Wachter R, et al. Elevated serum levels of interleukin-10 and tumor necrosis factor are both associated with vital exhaustion in patients with cardiovascular risk factors. Psychosomatics. 2010;51:248–56. doi: 10.1176/appi.psy.51.3.248. [DOI] [PubMed] [Google Scholar]
  • 22.Nicolson NA, van Diest R. Salivary cortisol patterns in vital exhaustion. J Psychosom Res. 2000;49:335–42. doi: 10.1016/s0022-3999(00)00166-5. [DOI] [PubMed] [Google Scholar]
  • 23.Igna CV, Julkunen J, Vanhanen H. Vital exhaustion, depressive symptoms and serum triglyceride levels in high-risk middle-aged men. Psychiatry Res. 2011;187:363–9. doi: 10.1016/j.psychres.2010.10.016. [DOI] [PubMed] [Google Scholar]
  • 24.Koertge J, Ahnve S, Schenck-Gustafsson K, Orth-Gomér K, Wamala S. Vital exhaustion in relation to lifestyle and lipid profile in healthy women. Int J Behav Med. 2003;10:44–55. doi: 10.1207/s15327558ijbm1001_04. [DOI] [PubMed] [Google Scholar]
  • 25.Kudielka BM, Bellingrath S, von Kanel R. Circulating fibrinogen but not d-dimer level is associated with vital exhaustion in school teachers. Stress. 2008;11:250–8. doi: 10.1080/10253890701714831. [DOI] [PubMed] [Google Scholar]
  • 26.von Kanel R, Frey K, Fischer J. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects. Scand Cardiovasc J. 2004;38:28–32. doi: 10.1080/14017430310015884. [DOI] [PubMed] [Google Scholar]
  • 27.Boudrez H, Denollet J, Amsel BJ, De Backer G, Walter PJ, De Beule J, et al. Psychological status of patients before and after coronary bypass surgery. Netherlands: Kluwer Academic Publishers; 1992. [Google Scholar]
  • 28.Boudrez H, De Backer G. Psychological status and the role of coping style after coronary artery bypass graft surgery. Results of a prospective study. Qual Life Res. 2001;10:37–47. doi: 10.1023/a:1016697719078. [DOI] [PubMed] [Google Scholar]
  • 29.Parolari A, Camera M, Alamanni F, Naliato M, Polvani GL, Agrifoglio M, et al. Systemic inflammation after on-pump and off-pump coronary bypass surgery: A one-month follow-up. Ann Thorac Surg. 2007;84:823–8. doi: 10.1016/j.athoracsur.2007.04.048. [DOI] [PubMed] [Google Scholar]
  • 30.Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–92. doi: 10.1097/01.MLR.0000093487.78664.3C. [DOI] [PubMed] [Google Scholar]
  • 31.Davidson KW, Kupfer DJ, Bigger JT, Califf RM, Carney RM, Coyne JC, et al. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group report. Psychosom Med. 2006;68:645–50. doi: 10.1097/01.psy.0000233233.48738.22. [DOI] [PubMed] [Google Scholar]
  • 32.Meesters C, Appels A. An interview to measure vital exhaustion. II. reliability and validity of the interview and correlations of vital exhaustion with personality characteristics. Psychol Health. 1996;11:573–81. [Google Scholar]
  • 33.Appels A, Bar F, van der Pol G, Erdman R, Assman M, Trijsburg W, et al. Effects of treating exhaustion in angioplasty patients on new coronary events: Results of the randomized Exhaustion Intervention Trial (EXIT) Psychosom Med. 2005;67:217–23. doi: 10.1097/01.psy.0000151485.38411.36. [DOI] [PubMed] [Google Scholar]
  • 34.Kop WJ. Somatic depressive symptoms, vital exhaustion, and fatigue: Divergent validity of overlapping constructs. Psychosom Med. 2012;74:442–5. doi: 10.1097/PSY.0b013e31825f30c7. [DOI] [PubMed] [Google Scholar]
  • 35.Cohen J. Statistical power analysis for the behavioral sciences. 2. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1988. [Google Scholar]
  • 36.Vroege EM, Zuidersma M, de Jonge P. Vital exhaustion and somatic depression: The same underlying construct in patients with myocardial infarction? Psychosom Med. 2012;74:446–51. doi: 10.1097/PSY.0b013e31825a7194. [DOI] [PubMed] [Google Scholar]
  • 37.Janszky I, Lekander M, Blom M, Georgiades A, Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun. 2005;19:555–63. doi: 10.1016/j.bbi.2005.01.001. [DOI] [PubMed] [Google Scholar]
  • 38.Kop WJ, Appels APWM, de Leon CFM, Bar FW. The relationship between severity of coronary artery disease and vital exhaustion. J Psychosom Res. 1996;40:397–405. doi: 10.1016/0022-3999(95)00613-3. [DOI] [PubMed] [Google Scholar]
  • 39.Appels A, Kop W, Bar F, De Swart H, De Leon CM. Vital exhaustion, extent of atherosclerosis, and the clinical course after successful percutaneous transluminal coronary angioplasty. Eur Heart J. 1995;16:1880–5. doi: 10.1093/oxfordjournals.eurheartj.a060842. [DOI] [PubMed] [Google Scholar]
  • 40.Smith ORF, Gidron Y, Kupper N, Winter JB, Denollet J. Vital exhaustion in chronic heart failure: Symptom profiles and clinical outcome. J Psychosom Res. 2009;66:195–201. doi: 10.1016/j.jpsychores.2008.10.021. [DOI] [PubMed] [Google Scholar]
  • 41.Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–8. doi: 10.1016/s0735-1097(02)01726-6. [DOI] [PubMed] [Google Scholar]
  • 42.Babyak MA, Blumenthal JA, Hinderliter A, Hoffman B, Waugh RA, Coleman RE, et al. Prognosis After Change in Left Ventricular Ejection Fraction During Mental Stress Testing in Patients With Stable Coronary Artery Disease. Am J Cardiol. 2010;105:25–8. doi: 10.1016/j.amjcard.2009.08.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ho C. White blood cell and platelet counts could affect whole blood viscosity. J Chin Med Assoc. 2004;67:394–7. [PubMed] [Google Scholar]
  • 44.Sabatine MS, Morrow DA, Giugliano RP, Burton PBJ, Murphy SA, McCabe CH, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111:2042–9. doi: 10.1161/01.CIR.0000162477.70955.5F. [DOI] [PubMed] [Google Scholar]
  • 45.Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, et al. Eosinophils: Biological properties and role in health and disease. Clin Exp Allergy. 2008;38:709–50. doi: 10.1111/j.1365-2222.2008.02958.x. [DOI] [PubMed] [Google Scholar]
  • 46.Sweetnam PM, Thomas HF, Yarnell JWG, Baker IA, Elwood PC. Total and differential leukocyte counts as predictors of ischemic heart disease: The Caerphilly and Speedwell studies. Am J Epidemiol. 1997;145:416–21. doi: 10.1093/oxfordjournals.aje.a009123. [DOI] [PubMed] [Google Scholar]
  • 47.Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in african-american and white men and women: Atherosclerosis Risk in Communities study. Am J Epidemiol. 2001;154:758–64. doi: 10.1093/aje/154.8.758. [DOI] [PubMed] [Google Scholar]
  • 48.Erdogan O, Gul C, Altun A, Ozbay G. Increased Immunoglobulin E Response in Acute Coronary Syndromes. Angiology. 2003;54:73–9. doi: 10.1177/000331970305400109. [DOI] [PubMed] [Google Scholar]
  • 49.Sakai T, Inoue S, Matsuyama T-a, Takei M, Ota H, Katagiri T, et al. Eosinophils may be involved in thrombus growth in acute coronary syndrome histologic examination of aspiration samples. Int Heart J. 2009;50:267–77. doi: 10.1536/ihj.50.267. [DOI] [PubMed] [Google Scholar]
  • 50.Rittersma SZH, Meuwissen M, van der Loos CM, Koch KT, de Winter RJ, Piek JJ, et al. Eosinophilic infiltration in restenotic tissue following coronary stent implantation. Atherosclerosis. 2006;184:157–62. doi: 10.1016/j.atherosclerosis.2005.03.049. [DOI] [PubMed] [Google Scholar]
  • 51.Steel JL, Kim KH, Dew MA, Unruh ML, Antoni MH, Olek MC, et al. Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: An exploratory study. J Pain Symptom Manage. 2010;39:859–71. doi: 10.1016/j.jpainsymman.2009.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, Kalos M, et al. High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med. 2008;233:1171–80. doi: 10.3181/0712-RM-328. [DOI] [PubMed] [Google Scholar]
  • 53.Niccoli G, Ferrante G, Cosentino N, Conte M, Belloni F, Marino M, et al. Eosinophil cationic protein: A new biomarker of coronary atherosclerosis. Atherosclerosis. 2010;211:606–11. doi: 10.1016/j.atherosclerosis.2010.02.038. [DOI] [PubMed] [Google Scholar]
  • 54.Bansilal S, Farkouh ME, Fuster V. Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol. 2007;99:6–14. doi: 10.1016/j.amjcard.2006.11.002. [DOI] [PubMed] [Google Scholar]
  • 55.Räikkönen K, Keltikangas-Järvinen L, Hautanen A. The role of psychological coronary risk factors in insulin and glucose metabolism. J Psychosom Res. 1994;38:705–13. doi: 10.1016/0022-3999(94)90023-x. [DOI] [PubMed] [Google Scholar]
  • 56.Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol. 2009;53:S14–S20. doi: 10.1016/j.jacc.2008.10.038. [DOI] [PubMed] [Google Scholar]
  • 57.McGowan L, Dickens C, Percival C, Douglas J, Tomenson B, Creed F. The relationship between vital exhaustion, depression and comorbid illnesses in patients following first myocardial infarction. J Psychosom Res. 2004;57:183–8. doi: 10.1016/S0022-3999(03)00610-X. [DOI] [PubMed] [Google Scholar]

RESOURCES